Josh Disbrow's guest appearances

Josh Disbrow

Passionate Pioneers with Mike Biselli

Logan & Lewis

Rare Care Podcast

Jon Wertheim

Ray Blakney

Adam Carolla

Bert Kreischer

Rob Lowe

Steve Rannazzisi

Duncan Trussell

Dee Snider

Derek Herrera

Benjamin Allbright

Mo Rocca

Jeff Bezos

James Franco

Scott Eastwood

Chuck Liddell

OwlTail

 Larry Luxner, senior correspondent for Rare Disease Advisor, interiews Josh Disbrow, CEO of Aytu Bio, a Colorado company developing potentially lifesaving products in the areas of pediatric onset and rare disease, particularly severe upper respiratory conditions.

Larry Luxner, senior correspondent for Rare Disease Advisor, interiews Josh Disbrow, CEO of Aytu Bio, a Colorado company developing potentially lifesaving products in the areas of pediatric onset and rare disease, particularly severe upper respiratory conditions.

33: An Interview with Josh Disbrow, CEO of Aytu Bio

With the COVID-19 outbreak bringing the world to its knees, it’s encouraging to see executives and organizations quickly respond to the emergency that’s right in front of us.This only speaks to who we are as a nation and the types of entrepreneurs that make this country so great.In this episode, I’m joined by Josh Disbrow, Chief Executive Officer of Aytu Bioscience. He’ll help us gain a better understanding about antibodies and COVID-19. Josh shares his organization’s journey in receiving their emergency authorization use for their COVID-19 rapid antibody test and why Aytu BioScience is perfectly positioned to help fight the global pandemic. We also receive a sneak peek into the company’s future innovation roadmap and why these new and forthcoming technologies have significant potential to save many lives impacted by this devastating disease. If you want to stay updated about Aytu Bioscience and its COVID-19 efforts, as well as the innovative products they are creating to help battle the pandemic, then you should definitely listen to this episode!EPISODE HIGHLIGHTS:How Aytu Bioscience is helping fight COVID-19Why antibody testing is important during the pandemicHow antibodies help with creating a vaccineOther technologies Aytu Bioscience is known for before the outbreakThe process of how antibody testing got into the marketplaceWhat emergency use authorization is and why it is importantHow Aytu Bioscience created their COVID-19 antibody testFuture technology that Aytu Bioscience is creatingABOUT OUR GUEST:Josh Disbrow is the Co-Founder, Chairman, and Chief Executive Officer of Aytu BioScience, Inc. (NASDAQ: AYTU). Founded in 2015, Aytu BioScience is a specialty pharmaceutical company engaged in the global commercialization of novel prescription therapeutics and consumer healthcare products. Josh has been in the life sciences industry for over twenty three years across pharmaceuticals, diagnostics, and medical devices. Prior to co-founding Aytu, Josh served as the Chief Operating Officer of Colorado-based Ampio Pharmaceuticals (NYSE MKT: AMPE) and co-founded the Luoxis Diagnostics subsidiary. LINKS SUPPORTING THIS EPISODE:Aytu Bioscience website: CLICK HEREJosh Disbrow’s LinkedIn page: CLICK HEREJosh Disbrow’s Twitter page: CLICK HEREJoin our online community: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

With the COVID-19 outbreak bringing the world to its knees, it’s encouraging to see executives and organizations quickly respond to the emergency that’s right in front of us.This only speaks to who we are as a nation and the types of entrepreneurs that make this country so great.In this episode, I’m joined by <a href="https://www.linkedin.com/in/joshua-disbrow-3805955/" rel="noopener noreferrer nofollow" target="_blank">Josh Disbrow</a>, Chief Executive Officer of <a href="https://aytubio.com/" rel="noopener noreferrer nofollow" target="_blank">Aytu Bioscience</a>. He’ll help us gain a better understanding about antibodies and COVID-19. Josh shares his organization’s journey in receiving their emergency authorization use for their COVID-19 rapid antibody test and why Aytu BioScience is perfectly positioned to help fight the global pandemic. We also receive a sneak peek into the company’s future innovation roadmap and why these new and forthcoming technologies have significant potential to save many lives impacted by this devastating disease. If you want to stay updated about Aytu Bioscience and its COVID-19 efforts, as well as the innovative products they are creating to help battle the pandemic, then you should definitely listen to this episode!EPISODE HIGHLIGHTS:<ul><li>How Aytu Bioscience is helping fight COVID-19</li><li>Why antibody testing is important during the pandemic</li><li>How antibodies help with creating a vaccine</li><li>Other technologies Aytu Bioscience is known for before the outbreak</li><li>The process of how antibody testing got into the marketplace</li><li>What emergency use authorization is and why it is important</li><li>How Aytu Bioscience created their COVID-19 antibody test</li><li>Future technology that Aytu Bioscience is creating</li></ul><h4> </h4><h4>ABOUT OUR GUEST:</h4>Josh Disbrow is the Co-Founder, Chairman, and Chief Executive Officer of Aytu BioScience, Inc. (NASDAQ: AYTU). Founded in 2015, Aytu BioScience is a specialty pharmaceutical company engaged in the global commercialization of novel prescription therapeutics and consumer healthcare products. Josh has been in the life sciences industry for over twenty three years across pharmaceuticals, diagnostics, and medical devices. Prior to co-founding Aytu, Josh served as the Chief Operating Officer of Colorado-based Ampio Pharmaceuticals (NYSE MKT: AMPE) and co-founded the Luoxis Diagnostics subsidiary. <h4>LINKS SUPPORTING THIS EPISODE:</h4><ul><li>Aytu Bioscience website: <a href="https://aytubio.com/" rel="noopener noreferrer nofollow" target="_blank">CLICK HERE</a></li><li>Josh Disbrow’s LinkedIn page: <a href="https://www.linkedin.com/in/joshua-disbrow-3805955/" rel="noopener noreferrer nofollow" target="_blank">CLICK HERE</a></li><li>Josh Disbrow’s Twitter page: <a href="https://twitter.com/josh_disbrow" rel="noopener noreferrer nofollow" target="_blank">CLICK HERE</a></li><li>Join our online community: <a href="https://www.passionatepioneers.com/" rel="noopener noreferrer nofollow" target="_blank">CLICK HERE</a></li><li>Subscribe to newsletter: <a href="https://docs.google.com/forms/d/e/1FAIpQLSdMruVv3Ekvwx2LGIWfxX-mINKwM5snMsIYmNLotNodfKw2rQ/viewform" rel="noopener noreferrer nofollow" target="_blank">CLICK HERE</a></li><li>Guest nomination form: <a href="https://docs.google.com/forms/d/e/1FAIpQLScqk_H_a79gCRsBLynkGp7JbdtFRWynTvPVV9ntOdEpExjQIQ/viewform" rel="noopener noreferrer nofollow" target="_blank">CLICK HERE</a></li></ul>

Expert Coronavirus Updates with Josh Disbrow | Session 15

Derreck Tuszka

Josh Disbrow, CEO of AYTU BioSciences and Derreck Tuszka, Broncos 7th Rd Pick